Contact

regenerative medicine

regenerative medicine

We are together in each step
Array ( [0] => WP_Term Object ( [term_id] => 804 [name] => corporate finace tecnológico [slug] => corporate-finace-tecnologico [term_group] => 0 [term_taxonomy_id] => 804 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 8 [filter] => raw ) [1] => WP_Term Object ( [term_id] => 153 [name] => global corporate finance [slug] => global-corporate-finance [term_group] => 0 [term_taxonomy_id] => 153 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 609 [filter] => raw ) [2] => WP_Term Object ( [term_id] => 133 [name] => Health Care [slug] => health-care [term_group] => 0 [term_taxonomy_id] => 133 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 2 [filter] => raw ) [3] => WP_Term Object ( [term_id] => 1284 [name] => medicina regenerativa [slug] => medicina-regenerativa [term_group] => 0 [term_taxonomy_id] => 1284 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 2 [filter] => raw ) )
Investment analysis in regenerative medicine. Histocell and Cell Innovation Partners
We analyse, from a corporate finance perspective, the case of Histocell, a biopharmaceutical company focused on the development of new drugs [...].
read more >>
Investment analysis in FinTech sector for business expense management. Captio and Certify.
We analyse, from a corporate finance point of view, the purchase of Captio - the Spanish startup that manages that [...]
read more >>
closechevron-downcrossmenuchevron-down